PacBio And Verily Health Announce Multi-Year Strategic Collaboration To Integrate PacBio HiFi Sequencing With Verily Health’s Governed Data And AI Platform
10/19/2026
Impact: 80
Healthcare
PacBio (NASDAQ: PACB) and Verily Health Inc. have announced a multi-year strategic collaboration to integrate PacBio's HiFi sequencing technology with Verily's governed data and AI platform. This partnership aims to combine long-read genomic data with real-world clinical data, creating AI-ready clinico-genomic datasets to enhance biomedical discovery and AI model training. The collaboration addresses challenges in processing complex biological data and aims to make genomic insights more accessible for future biomedical AI applications.
AI summary, not financial advice
Share: